Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity

Cell(2023)10.1016/j.cell.2023.06.002Source: DataRank Database

Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity is a research paper published in Cell (2023). On theSindex it has a DataRank of 0. It has been cited 204 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access204 citations

Download PDF

Cite:

Linked data & code

geo cellosaurus rrid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 23.82)OA: hybridTopics (50)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Alexander Hostetler ORCID,Duncan M. Morgan ORCID,Laura Maiorino ORCID,Ina Sulkaj ORCID,Charles A. Whittaker ORCID

Live enrichment

PubMed:37413990 PMC:PMC10372881 OpenAlex:https://openalex.org/W4383218197

NIBIB NIH HHS

Grant: R01 EB022433

NIAID NIH HHS

Grant: DP2 AI164319

NCI NIH HHS

Grant: R01 CA247632

Medical Research Council

Grant: MR/X020258/1

NCI NIH HHS

Grant: P30 CA014051

National Institutes of Health

Grant: 1R01EB022433-01A1

Lymph node-targeted molecular vaccines

National Institutes of Health

Grant: 5P30CA014051-17

CELL BIOLOGY--DEVELOPMENTAL PROGRAM

Howard Hughes Medical Institute

FWCI

23.82

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by

journalhttp://www.cell.com/article/S0092867423006426/pdf

publisherhttp://www.cell.com/article/S0092867423006426/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867423006426?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867423006426?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cell.2023.06.002

Fields of Study

CAR-T cell therapy researchImmune Cell Function and InteractionVirus-based gene therapy research03 medical and health sciences0302 clinical medicineHumansReceptors, Chimeric AntigenNeoplasmsT-LymphocytesImmunotherapy, AdoptiveCancer VaccinesReceptors, Antigen, T-Cell

MeSH Terms

Receptors, Chimeric AntigenHumansNeoplasmsReceptors, Antigen, T-CellT-LymphocytesImmunotherapy, AdoptiveCancer Vaccines

Keywords

BiologyAntigenChimeric antigen receptorPriming (agriculture)ImmunologyImmune systemTumor antigenTumor microenvironmentCancer researchEndogenyCrosstalkT cellImmunotherapyCancerVaccineIFN-γSolid tumorTumor HeterogeneityAntigen SpreadingAntigenic HeterogeneityCar TAntigen LossChimeric Antigen Receptor T cellReceptors, Chimeric AntigenNeoplasmsT-LymphocytesReceptors, Antigen, T-CellHumansImmunotherapy, AdoptiveCancer VaccinesArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being